EDGAR Filing Documents for 0001437749-13-007693

Form 8-K - Current report:

SEC Accession No. 0001437749-13-007693

Filing Date

2013-06-17

Accepted

2013-06-17 14:55:16

Documents

Period of Report

2013-06-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	ugne20130617b_8k.htm	8-K	66013
2	EXHIBIT 10.1	ugne20130617b_8kex10-1.htm	EX-10	113220
3	EXHIBIT 10.2	ugne20130617b_8kex10-2.htm	EX-10	113594
4	EXHIBIT 10.3	ugne20130617b_8kex10-3.htm	EX-10	113553
5	EXHIBIT 10.4	ugne20130617b_8kex10-4.htm	EX-10	112915
	Complete submission text file	0001437749-13-007693.txt		520740

Mailing Address 81 FULTON STREET BOONTON NJ 07005

Business Address 81 FULTON STREET BOONTON NJ 07005 973-265-1100

UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)